- Access
- Approved drug
- Cost / month
- ≈ €540–650
- researchers' estimate; no listing to price
r/ibs· · 23 upvotesOriginal ↗
I take trulance myself and guys I gotta tell you it changed my life. I was so constipated I was going ten days without a single bowel movement.
GlowingOral
severe constipation where diet, supplements and laxatives failed
r/ibs· · 8 upvotesOriginal ↗
Glad I ignored people saying that Trulance was going to give the same effect as Linzess.
GlowingOral · about 3 weeks
switched after Linzess had little effect
r/ConstipationAdvice· · 8 upvotesOriginal ↗
It is now 3am and I’m still running to the toilet at least once every 30 minutes. This can’t be healthy I was literally just in the hospital
NegativeOral · first dose
taken two days after a hospital stay for gastroenteritis
- Strict case
- The label warns of severe diarrhoea (0.6-1% in trials, most within the first days) with instructions to stop and rehydrate, and Reddit users describe days of watery diarrhoea leaving them badly dehydrated. Its sibling linaclotide has post-marketing hospitalisations for the same harm. It is obvious and stops when the drug does, so under a doctor it is a reasonable constipation treatment, but it is a real route to serious harm and does not belong on a clean wellness list.
- Users report
- Much like Linzess, and the two are often tried in turn because insurers require it. 11 of 25 reports are favourable: some who got nowhere on Linzess call Trulance a godsend or 'more predictable', and a few long-term users with almost no colon motility say they cannot go without it. The rest describe the same class problems: a first dose that empties the bowel for hours, days of liquid stools, accidents at work, insane bloating, or cramps with no result. Two describe dehydration bad enough to feel faint or set off a rheumatoid flare. For several, the effect faded after a few weeks. Felt nothing: 4 of 25 reports (16%) felt nothing; a few more found it stopped working after weeks.
- Best effects
- More frequent, softer bowel movements, usually within hours · less bloating and IBS-C abdominal pain · a second chance for people Linzess failed or overwhelmed
- Downsides
- Diarrhoea (5% vs 1% placebo on the label's stricter definition), often explosive in the first days · bloating or cramping without a bowel movement in some · effect can fade after weeks · insurers usually require a Linzess trial first; costly uninsured
- Watch
- Severe diarrhoea and dehydration (0.6-1% severe in trials, mostly within the first 1-3 days) · Boxed warning: contraindicated under 6 years and to be avoided under 18 (juvenile mice died of dehydration) · Contraindicated with known or suspected mechanical bowel obstruction · Rare hypersensitivity (itching, hives, rash) and isolated liver-enzyme rises in trials
- Evidence
- Approved drug — FDA-approved 2017 for chronic idiopathic constipation, later extended to IBS-C, adults only; four phase 3 RCTs with over 3,000 adults on drug or placebo
- Caveat
- Plecanatide's label shows less diarrhoea than linaclotide's, but its trials used a stricter definition, and a meta-regression found no real difference; whether it is gentler for a given person is trial and error, and people switch between the two (never combine them) when one fades or is too harsh. Gains over placebo are modest (about 1 in 10 extra responders). It stays in the gut and has no known slow or hidden harm.
- Typical use
- 3 mg once daily, with or without food (both CIC and IBS-C). Users sometimes halve the tablet or take it every other day to tame diarrhoea.
- Getting it
- Prescription drug in the US (Trulance, Salix/Bausch). Pharmacy-dispensed and minimally absorbed, so product quality is not an issue; US insurers often cover it only after Linzess (or Amitiza) has failed.
- Stacked with
- Prucalopride (Motegrity): Added for slow transit by users for whom Trulance alone is not enough. · Magnesium oxide or Miralax: Osmotic laxatives on top, or on off days by those who take Trulance every other day to avoid liquid stools.